查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2017777

牙科膜和骨移植替代材料市場規模、佔有率和趨勢分析報告：按產品、應用、地區和細分市場分類（2026-2033 年）

Dental Membrane And Bone Graft Substitutes Market Size, Share & Trends Analysis Report By Product, By Application, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格

牙科膜和骨移植替代材料市場概述

2025年全球牙科膜和骨移植替代材料市場價值為15.8億美元，預計到2033年將達到29.6億美元，2026年至2033年的複合年成長率為8.32%。

由於牙科疾病負擔日益加重，以及人們對美容和修復牙科治療的需求不斷成長，對牙科膜和骨移植替代材料的需求也在增加。

此外，牙科旅遊的興起也預計將推動該產業的發展。包括牙周病、齲齒、牙齒脫落和口腔癌在內的牙科疾病在全球範圍內的日益普遍，顯著提升了對牙科膜和骨移植替代材料的需求。根據世界衛生組織（WHO）2025年3月發布的數據，全球將有超過10億人患有嚴重的牙周病。此外，約7%的20歲以上成年人和約23%的60歲以上成年人將經歷牙齒全部脫落，通常需要進行植入或骨再生手術。由於牙齒脫落往往會導致下顎骨劣化，而骨移植替代材料或薄膜對於植入的成功植入至關重要，因此這些數據凸顯了對人工植牙和骨再生手術日益成長的需求。

此外，口腔癌發生率的不斷上升預計將進一步增加對牙科骨移植材料的需求。在口腔癌的外科治療中，通常需要進行骨移植來重組和修復因腫瘤切除而受損或缺失的下顎骨區域。這表明骨移植替代材料在促進手術成功和術後復原方面發揮著至關重要的作用。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：牙科膜和骨移植替代材料的市場：變數、趨勢和範圍

  • 市場譜系展望
  • 市場動態
  • 牙科膜和骨移植材料替代品的市場分析工具

第4章：牙科膜和骨移植替代材料的市場：產品特定估算和趨勢分析

  • 全球牙科膜和骨移植替代材料市場：產品波動分析
  • 全球牙科膜和骨移植替代材料市場：產品規模和趨勢分析，2021-2033年
  • 骨移植替代材料（BGS）
  • 牙科膜和軟組織再生材料

第5章：牙科膜和骨移植替代材料的市場：按應用分類的估算和趨勢分析

  • 全球牙科膜和骨移植替代材料市場：基於應用的波動分析
  • 全球牙科膜和骨移植替代材料市場：基於應用的市場規模和趨勢分析，2021-2033年
  • 齒槽嵴增高手術
  • 鼻竇增高術
  • 牙周組織缺損的再生
  • 植入骨再生
  • 套接字存儲
  • 軟組織再生
  • 其他

第6章：牙科膜和骨移植替代材料市場：區域估算和趨勢分析

  • 區域儀錶板
  • 市場規模、預測與趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 印度
    • 中國
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • UAE
    • 科威特

第7章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司和競爭對手的分類
    • 創新者
  • 供應商情況
    • 主要銷售代理商和通路夥伴名單
    • Key customers
    • Global Key company market share analysis, 2025
    • Dentsply Sirona
    • Bioteck SpA
    • Maxigen Biotech Inc.
    • Institut Straumann AG
    • Nobel Biocare Services AG（Envista）
    • Geistlich Holding
    • ZimVie Inc.
    • NovaBone（Halma）
    • Osteogenics Biomedical（Envista）
    • Regenity
    • Medtronic
    • BioHorizons
    • REGEDENT AG
    • IDL Dental Technologies LTD
    • EUCARE PHARMACEUTICALS（P）LTD
    • Curasan, Inc.
    • TBR Dental
    • DentiumUSA
    • Tecnoss Dental Srl（Tecnoss srl）
    • Unicare Biomedical, Inc.
    • Neoss
    • Advanced Medical Solutions Group plc
    • B&B Dental Implant Company
    • Botiss
    • Septodont Holding
    • Implant Direct Corporation（Envista）
    • META BIOMED CO,. LTD
    • SigmaGraft Biomaterials
  • 公司熱圖分析與市場分析
  • 2024年企業市場占有率預測分析
  • 其他主要市場公司
Product Code: GVR-4-68040-740-6

Dental Membrane And Bone Graft Substitutes Market Summary

The global dental membrane and bone graft substitutes market size was valued at USD 1.58 billion in 2025 and is projected to reach USD 2.96 billion by 2033, growing at a CAGR of 8.32% from 2026 to 2033. The demand for dental membranes and bone graft substitutes is rising owing to the increasing burden of dental disorders and the growing demand for aesthetic and restorative dental procedures.

In addition, increasing dental tourism is also expected to propel the industry. The rising global prevalence of dental disorders, including periodontal disease, tooth decay, tooth loss, and oral cancer, significantly drives demand in the dental membrane and bone graft substitutes market. According to World Health Organization data published in March 2025, more than 1 billion people suffer from severe periodontal disease worldwide. Additionally, about 7% of adults aged 20 and above and around 23% of those over 60 experience complete tooth loss, often requiring implants and bone regeneration procedures. These statistics underscore the growing necessity for dental implants and bone regeneration procedures, as tooth loss frequently leads to jawbone deterioration, requiring bone graft substitutes and membranes to support successful implant integration.

Moreover, the increasing incidence of oral cancer is anticipated to boost the demand for dental bone grafts further. During surgical treatment for oral cancer, bone grafts are frequently required to reconstruct and restore areas of the jawbone that have been damaged or removed during tumor excision. This underscores the vital role that bone graft substitutes play in facilitating successful surgical outcomes and post-operative rehabilitation.

Global Dental Membrane And Bone Graft Substitutes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global dental membrane and bone graft substitutes market report based on product, application, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Bone Graft Substitutes (BGS)
    • Allograft
    • Demineralized Bone Matrix
    • Others
    • Autograft
    • Xenograft
    • Bovine Derived
    • Porcine Derived
    • Others
    • Synthetic
    • Hydroxyapatite (HA)
    • Tricalcium Phosphate (TCP)
    • Bioactive Glass
    • Others
  • Dental Membranes and Soft Tissue Regeneration Materials
    • Resorbable Membranes
    • Bovine -derived collagen based
    • Porcine derived collagen based
    • Others
    • Non- Resorbable Membrane
    • Expanded PTFE (ePTFE)
    • Dense PTFE (dPTFE)
    • Titanium-Reinforced PTFE
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Ridge Augmentation
  • Sinus Lift
  • Periodontal Defect Regeneration
  • Implant Bone Regeneration
  • Socket Preservation
  • Soft Tissue Regeneration
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Dental Membrane And Bone Graft Substitutes Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising burden of dental disorders
      • 3.2.1.2. Development of synthetic bone grafts
      • 3.2.1.3. Growing demand for aesthetic and restorative dental procedures
      • 3.2.1.4. Increasing dental tourism
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of dental treatments
      • 3.2.2.2. Potential risks and complications associated with dental procedures
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing number of clinical trials
      • 3.2.3.2. Growing development & approvals of resorbable membranes
      • 3.2.3.3. Expansion into synthetic membrane
      • 3.2.3.4. Strategic partnerships & investment to enhance market presence
      • 3.2.3.5. Expansion opportunities in emerging economies
      • 3.2.3.6. Increasing demand for composite bone grafts
      • 3.2.3.7. Growing focus on 3D printed and custom grafts
    • 3.2.4. Market challenge analysis
      • 3.2.4.1. Regulatory and approval complexities
      • 3.2.4.2. Economic and currency exchange risks
  • 3.3. Dental Membrane And Bone Graft Substitutes Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political & Legal Landscape
      • 3.3.2.2. Economic and Social Landscape
      • 3.3.2.3. Technological landscape

Chapter 4. Dental Membrane And Bone Graft Substitutes Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Dental Membrane And Bone Graft Substitutes Market Product Movement Analysis
  • 4.3. Global Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Product 2021 to 2033 (USD Million)
  • 4.4. Bone Graft Substitutes (BGS)
    • 4.4.1. Bone graft substitutes (BGS) market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.1. Allograft
        • 4.4.1.1.1. Allograft market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.1.1.1. Demineralized Bone Matrix
            • 4.4.1.1.1.1.1. Demineralized bone matrix market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.1.1.2. Others
            • 4.4.1.1.1.2.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.2. Autograft
        • 4.4.1.2.1. Autograft market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.3. Xenograft
        • 4.4.1.3.1. Xenograft market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.1. Bovine Derived
            • 4.4.1.3.1.1.1. Bovine derived market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.2. Porcine Derived
            • 4.4.1.3.1.2.1. Porcine derived market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.3.1.3. Others
            • 4.4.1.3.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.4.1.4. Synthetic
        • 4.4.1.4.1. Synthetic market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.1. Hydroxyapatite (HA)
            • 4.4.1.4.1.1.1. Hydroxyapatite (HA) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.2. Tricalcium Phosphate (TCP)
            • 4.4.1.4.1.2.1. Tricalcium phosphate (TCP) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.3. Bioactive Glass
            • 4.4.1.4.1.3.1. Bioactive glass market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.4.1.4.1.4. Others
            • 4.4.1.4.1.4.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
  • 4.5. Dental Membranes and Soft Tissue Regeneration Materials
    • 4.5.1. Dental membranes and soft tissue regeneration materials market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.1. Resorbable membranes
        • 4.5.1.1.1. Resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.1. Bovine -derived collagen based
            • 4.5.1.1.1.1.1. Bovine -derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.2. Porcine derived collagen based
            • 4.5.1.1.1.2.1. Porcine derived collagen based market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.1.1.3. Others
            • 4.5.1.1.1.3.1. Others market estimates and forecasts for 2021 to 2033 (USD Million)
      • 4.5.1.2. Non resorbable membranes
        • 4.5.1.2.1. Non resorbable membranes market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.1. Expanded PTFE (ePTFE)
            • 4.5.1.2.1.1.1. Expanded PTFE (ePTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.2. Dense PTFE (dPTFE)
            • 4.5.1.2.1.2.1. Dense PTFE (dPTFE) market estimates and forecasts for 2021 to 2033 (USD Million)
          • 4.5.1.2.1.3. Titanium-Reinforced PTFE
            • 4.5.1.2.1.3.1. Titanium-reinforced PTFE market estimates and forecasts for 2021 to 2033 (USD Million)

Chapter 5. Dental Membrane And Bone Graft Substitutes Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Dental Membrane And Bone Graft Substitutes Market Application Movement Analysis
  • 5.3. Global Dental Membrane And Bone Graft Substitutes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 5.4. Ridge Augmentation
    • 5.4.1. Ridge augmentation market estimates and forecast 2021 to 2033 (USD Million)
  • 5.5. Sinus Lift
    • 5.5.1. Sinus lift market estimates and forecast 2021 to 2033 (USD Million)
  • 5.6. Periodontal Defect Regeneration
    • 5.6.1. Periodontal defect regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.7. Implant Bone Regeneration
    • 5.7.1. Implant bone regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.8. Socket Preservation
    • 5.8.1. Socket preservation market estimates and forecasts for 2021 to 2033 (USD Million)
  • 5.9. Soft Tissue Regeneration
    • 5.9.1. Soft tissue regeneration market estimates and forecast 2021 to 2033 (USD Million)
  • 5.10. Others
    • 5.10.1. Others market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. Dental Membrane And Bone Graft Substitutes Market: Regional Estimates & Trend Analysis By Product and By Application

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
  • 6.3. North America
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Competitive scenario
      • 6.3.2.3. Regulatory framework
      • 6.3.2.4. Reimbursement scenario
      • 6.3.2.5. U.S. market estimates and forecasts, 2021 - 2033
    • 6.3.3. Canada
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Competitive scenario
      • 6.3.3.3. Regulatory framework
      • 6.3.3.4. Reimbursement scenario
      • 6.3.3.5. Canada market estimates and forecasts, 2021 - 2033
    • 6.3.4. Mexico
      • 6.3.4.1. Key country dynamics
      • 6.3.4.2. Competitive scenario
      • 6.3.4.3. Regulatory framework
      • 6.3.4.4. Reimbursement scenario
      • 6.3.4.5. Mexico market estimates and forecasts, 2021 - 2033
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Competitive scenario
      • 6.4.1.3. Regulatory framework
      • 6.4.1.4. Reimbursement scenario
      • 6.4.1.5. UK market estimates and forecasts, 2021 - 2033
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Competitive scenario
      • 6.4.2.3. Regulatory framework
      • 6.4.2.4. Reimbursement scenario
      • 6.4.2.5. Germany market estimates and forecasts, 2021 - 2033
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Competitive scenario
      • 6.4.3.3. Regulatory framework
      • 6.4.3.4. Reimbursement scenario
      • 6.4.3.5. France market estimates and forecasts, 2021 - 2033
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Competitive scenario
      • 6.4.4.3. Regulatory framework
      • 6.4.4.4. Reimbursement scenario
      • 6.4.4.5. Italy market estimates and forecasts, 2021 - 2033
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Competitive scenario
      • 6.4.5.3. Regulatory framework
      • 6.4.5.4. Reimbursement scenario
      • 6.4.5.5. Spain market estimates and forecasts, 2021 - 2033
    • 6.4.6. Denmark
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Competitive scenario
      • 6.4.6.3. Regulatory framework
      • 6.4.6.4. Reimbursement scenario
      • 6.4.6.5. Denmark market estimates and forecasts, 2021 - 2033
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Competitive scenario
      • 6.4.7.3. Regulatory framework
      • 6.4.7.4. Reimbursement scenario
      • 6.4.7.5. Sweden market estimates and forecasts, 2021 - 2033
    • 6.4.8. Norway
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Competitive scenario
      • 6.4.8.3. Regulatory framework
      • 6.4.8.4. Reimbursement scenario
      • 6.4.8.5. Norway market estimates and forecasts, 2021 - 2033
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Competitive scenario
      • 6.5.1.3. Regulatory framework
      • 6.5.1.4. Reimbursement scenario
      • 6.5.1.5. Japan market estimates and forecasts, 2021 - 2033
    • 6.5.2. India
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Competitive scenario
      • 6.5.2.3. Regulatory framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. India market estimates and forecasts, 2021 - 2033
    • 6.5.3. China
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Competitive scenario
      • 6.5.3.3. Regulatory framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. China market estimates and forecasts, 2021 - 2033
    • 6.5.4. South Korea
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Competitive scenario
      • 6.5.4.3. Regulatory framework
      • 6.5.4.4. Reimbursement scenario
      • 6.5.4.5. South Korea market estimates and forecasts, 2021 - 2033
    • 6.5.5. Australia
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Competitive scenario
      • 6.5.5.3. Regulatory framework
      • 6.5.5.4. Reimbursement scenario
      • 6.5.5.5. Australia market estimates and forecasts, 2021 - 2033
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Competitive scenario
      • 6.5.6.3. Regulatory framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. Thailand market estimates and forecasts, 2021 - 2033
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Competitive scenario
      • 6.6.1.3. Regulatory framework
      • 6.6.1.4. Reimbursement scenario
      • 6.6.1.5. Brazil market estimates and forecasts, 2021 - 2033
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Competitive scenario
      • 6.6.2.3. Regulatory framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Argentina market estimates and forecasts, 2021 - 2033
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Competitive scenario
      • 6.7.1.3. Regulatory framework
      • 6.7.1.4. Reimbursement scenario
      • 6.7.1.5. South Africa market estimates and forecasts, 2021 - 2033
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Competitive scenario
      • 6.7.2.3. Regulatory framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Competitive scenario
      • 6.7.3.3. Regulatory framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. UAE market estimates and forecasts, 2021 - 2033
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Competitive scenario
      • 6.7.4.3. Regulatory framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
    • 7.2.1. Innovators
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Global Key company market share analysis, 2025
    • 7.3.4. Dentsply Sirona
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. Bioteck S.p.A.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Maxigen Biotech Inc.
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Institut Straumann AG
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Nobel Biocare Services AG (Envista)
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Geistlich Holding
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. ZimVie Inc.
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. NovaBone (Halma)
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. Osteogenics Biomedical (Envista)
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Regenity
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Medtronic
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. BioHorizons
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. REGEDENT AG
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. IDL Dental Technologies LTD
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. EUCARE PHARMACEUTICALS (P) LTD
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. Curasan, Inc.
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. TBR Dental
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiatives
    • 7.3.21. DentiumUSA
      • 7.3.21.1. Company overview
      • 7.3.21.2. Financial performance
      • 7.3.21.3. Product benchmarking
      • 7.3.21.4. Strategic initiatives
    • 7.3.22. Tecnoss Dental Srl (Tecnoss s.r.l.)
      • 7.3.22.1. Company overview
      • 7.3.22.2. Financial performance
      • 7.3.22.3. Product benchmarking
      • 7.3.22.4. Strategic initiatives
    • 7.3.23. Unicare Biomedical, Inc.
      • 7.3.23.1. Company overview
      • 7.3.23.2. Financial performance
      • 7.3.23.3. Product benchmarking
      • 7.3.23.4. Strategic initiatives
    • 7.3.24. Neoss
      • 7.3.24.1. Company overview
      • 7.3.24.2. Financial performance
      • 7.3.24.3. Product benchmarking
      • 7.3.24.4. Strategic initiatives
    • 7.3.25. Advanced Medical Solutions Group plc
      • 7.3.25.1. Company overview
      • 7.3.25.2. Financial performance
      • 7.3.25.3. Product benchmarking
      • 7.3.25.4. Strategic initiatives
    • 7.3.26. B&B Dental Implant Company
      • 7.3.26.1. Company overview
      • 7.3.26.2. Financial performance
      • 7.3.26.3. Product benchmarking
      • 7.3.26.4. Strategic initiatives
    • 7.3.27. Botiss
      • 7.3.27.1. Company overview
      • 7.3.27.2. Financial performance
      • 7.3.27.3. Product benchmarking
      • 7.3.27.4. Strategic initiatives
    • 7.3.28. Septodont Holding
      • 7.3.28.1. Company overview
      • 7.3.28.2. Financial performance
      • 7.3.28.3. Product benchmarking
      • 7.3.28.4. Strategic initiatives
    • 7.3.29. Implant Direct Corporation (Envista)
      • 7.3.29.1. Company overview
      • 7.3.29.2. Financial performance
      • 7.3.29.3. Product benchmarking
      • 7.3.29.4. Strategic initiatives
    • 7.3.30. META BIOMED CO,. LTD
      • 7.3.30.1. Company overview
      • 7.3.30.2. Financial performance
      • 7.3.30.3. Product benchmarking
      • 7.3.30.4. Strategic initiatives
    • 7.3.31. SigmaGraft Biomaterials
      • 7.3.31.1. Company overview
      • 7.3.31.2. Financial performance
      • 7.3.31.3. Product benchmarking
      • 7.3.31.4. Strategic initiatives
  • 7.4. Heat Map Analysis/ Company Market Position Analysis
  • 7.5. Estimated Company Market Share Analysis, 2024
  • 7.6. List of Other Key Market Players

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 4 North America dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 5 North America dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 6 U.S dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 8 Canada dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 9 Canada dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 10 Mexico dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 11 Mexico dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 12 Europe dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 13 Europe dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 14 Europe dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 15 UK dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 16 UK dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 17 Germany dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 18 Germany dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 19 France dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 20 France dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 21 Italy dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 22 Italy dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 23 Spain dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 24 Spain dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 25 Denmark dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 26 Denmark dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 27 Sweden dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 28 Sweden dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 29 Norway dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 30 Norway dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 31 Asia Pacific dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 32 Asia Pacific dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 33 China dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 34 China dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 35 Japan dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 36 Japan dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 37 India dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 38 India dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 39 South Korea dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 40 South Korea dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 41 Australia dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 42 Australia dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 43 Thailand dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 44 Thailand dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 45 Latin America dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 46 Latin America dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 47 Latin America dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 48 Brazil dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 49 Brazil dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 50 Argentina dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 51 Argentina dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 52 Middle East & Africa dental membrane and bone graft substitutes market, by country, 2021 - 2033 (USD Million)
  • Table 53 Middle East & Africa dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 54 Middle East & Africa dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 55 South Africa dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 56 South Africa dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 57 Saudi Arabia dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 58 Saudi Arabia dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 59 UAE dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 60 UAE dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)
  • Table 61 Kuwait dental membrane and bone graft substitutes market, by product, 2021 - 2033 (USD Million)
  • Table 62 Kuwait dental membrane and bone graft substitutes market, by application, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Dental Membrane And Bone Graft Substitutes Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Regional Marketplace: Key Takeaways
  • Fig. 14 Dental membrane and bone graft substitutes market: Product movement analysis
  • Fig. 15 Bone Graft Substitutes (BGS) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Allograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Demineralized Bone Matrix Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Autograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Xenograft Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Bovine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Porcine Derived Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Synthetic Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Hydroxyapatite (HA) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Tricalcium Phosphate (TCP) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Bioactive Glass Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Dental Membranes and Soft Tissue Regeneration Materials Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Resorbable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Bovine -Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Porcine Derived Collagen Based Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Non Resobable Membranes Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Expanded PTFE (ePTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Dense PTFE (dPTFE) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Titanium-Reinforced PTFE Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Dental Membrane And Bone Graft Substitutes Market: Application Movement Analysis
  • Fig. 39 Ridge Augmentation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Sinus Lift Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Periodontal Defect Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Implant Bone Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Socket Preservation Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Soft Tissue Regeneration Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Regional Outlook, 2025 & 2033
  • Fig. 47 North America Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 48 U.S. Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 49 Canada Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 50 Mexico Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 51 Europe Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 52 Germany Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 53 UK Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 54 France Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 55 Italy Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 56 Spain Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 57 Denmark Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 58 Sweden Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 59 Norway Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 60 Asia Pacific Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 61 Japan Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 62 China Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 63 India Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 64 Australia Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 65 South Korea Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 66 Thailand Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 67 Latin America Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 68 Brazil Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 69 Argentina Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 70 Middle East and Africa Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 71 South Africa Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 72 Saudi Arabia Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 73 UAE Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)
  • Fig. 74 Kuwait Dental Membrane And Bone Graft Substitutes Market, 2021 - 2033 (USD Million)